Companies · Medical Devices

Vicarious Surgical Inc.

CHARLESTOWN · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Vicarious Surgical Inc. — recommendation, valuation, rhythm, risks.
$55.9M
Total raised · real
7
Rounds
0.9×
Latest step-up
Top 7%
Sector rank · raised
Series B
Latest stage · inferred · Thu Oct 09 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Vicarious Surgical Inc. has raised $56M over 7 rounds; too few niche peers to rank its valuation yet.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Active
  • Last raise 9 mo ago; this sector typically re-raises about every 16 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Vicarious Surgical Inc. is one of 233 Medical Devices companies tracked from CHARLESTOWN. By capital raised it ranks among the largest (ahead of 94% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
1
Investors (latest)
2025-10-09
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeed · 2016-02-05 Raised $2.4M (real) Modeled valuation $71M (est)Seed2016Seed · 2016-05-23 Raised $1.0M (real) Modeled valuation $30M (est)Seed2016Seed · 2016-10-07 Raised $800K (real) Modeled valuation $24M (est)Seed2016Series B · 2018-01-04 Raised $17M (real) Modeled valuation $444M (est)Series B2018Series A · 2018-01-04 Raised $13M (real) Modeled valuation $308M (est)Series A2018Series B · 2019-01-16 Raised $10M (real) Modeled valuation $265M (est)Series B2019Series B · 2020-07-02 Raised $13M (real) Modeled valuation $350M (est)Series B2020Series B · 2025-10-09 Raised $12M (real) Modeled valuation $51M (est)Series B2025+$1.0M+$800K+$17M+$13M+$10M+$13M+$12MCumulative $69M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$2.4M · 2016
Seed extension$1.0M · 2016
Seed extension$800K · 2016
Series B$16.8M · 2018no Series A on file
Bridge · Series B-stage$12.7M · 2018smaller follow-on
Series B extension$10.0M · 2019
Series B extension$13.2M · 2020
Series B extension$11.7M · 2025

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 75%.

Modeled valuation trajectory
$51.2M
Base estimate est.
$26.4M
Conservative case
$71.8M
Upside case
$65.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Seed · modeled $70.7M · 2016-02-052016Seed · modeled $29.6M · 2016-05-23Seed · modeled $23.7M · 2016-10-07Series B · modeled $444.0M · 2018-01-04Series A · modeled $307.6M · 2018-01-04Series B · modeled $264.9M · 2019-01-16Series B · modeled $349.5M · 2020-07-02Series B · modeled $51.2M · 2025-10-092025
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
61%
Survival probability
41% low · 75% high
1.41×/yr
Annual markup
1.71×/yr upside case
0.7 yr
Elapsed time used
0.7 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
17 mo
Avg between rounds
$5.8M/yr
Capital velocity
10.4 yr
On record since
2016
First round
8
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 22× above median
This company$55.9M
Sector median$2.6M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.7× of median
This company$11.7M
Sector median$16.7M
Modeled value — vs sector median (estimate, all stages) 3.3× above median
This company$51.2M
Sector median$15.4M

Raised more than 94% of sector peers (real $). Modeled value above 77% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful.

This companyCohort peer
$10.0M$100.0M$10.0M$100.0MCapital raised (log)Surgical Safety Technologies Inc. · Series B Raised $33.2M · modeled $70.3M (est)MedCrypt Inc. · Series B Raised $39.7M · modeled $45.6M (est)Vicarious Surgical Inc. (this company) Raised $55.9M · modeled $51.2M (est)Vicarious Surgical Inc.
CompanyStageRaised · realValue · estvs peer med.
Surgical Safety Technologies Inc.Series B$33.2M$70.3M1.37×
Vicarious Surgical Inc. this companySeries B$55.9M$51.2M1.00×
MedCrypt Inc.Series B$39.7M$45.6M0.89×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$2.4M2016-02-05$11.9M$70.7M85%
Seed$1.0M2016-05-23$5.0M$29.6M85%
Seed$800K2016-10-07$4.0M$23.7M90%
Series B$16.8M2018-01-04$93.1M$444.0M90%
Series A$12.7M2018-01-04$58.0M$307.6M90%
Series B$10.0M2019-01-16$55.6M$264.9M90%
Series B$13.2M2020-07-02$73.3M$349.5M90%
Series B$11.7M2025-10-09$65.2M$51.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$2.4M2016-02-05
    • First recorded raise — entered as Seed.
    • 11 investors on this round.
  2. Seed$1.0M2016-05-23
    • Came back fast: 4 mo vs the ~16 mo sector norm.
    • Round 2.4× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  3. Seed$800K2016-10-07
    • Came back fast: 5 mo vs the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
  4. Series B$16.8M2018-01-04
    • Raised 15 mo later, in step with the ~16 mo sector norm.
    • Round 20.9× larger than the prior — scaling up.
    • 9 investors on this round.
  5. Series A$12.7M2018-01-04
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round 1.3× smaller than the prior — bridge or down round.
    • 2 investors on this round.
  6. Series B$10.0M2019-01-16
    • Raised 12 mo later, in step with the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 6 investors on this round.
  7. Series B$13.2M2020-07-02
    • Raised 18 mo later, in step with the ~16 mo sector norm.
    • Round 1.3× larger than the prior — scaling up.
    • 6 investors on this round.
  8. Series B$11.7M2025-10-09
    • Raised again after 63 mo — slower than the ~16 mo sector norm.
    • Round roughly the size of the prior one.
    • 1 investor on this round.
Intelligence
2027 ~Q1
Modeled next raise · ~17mo cadence
$11.7M
Modeled next size est.range $11.7M$18.8M
0.9×
Last step-up
$5.8M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Samir Kaul31 other2018-01
DROR BERMAN7 other2018-01
Beverly Huss3 other2025-10
Ric Fulop3 other2020-07
Barry Greene2 other2016-02
Neil Devani2 other2016-02
Sarah Romano2 other2025-10
Adam Sachs1 other2016-02
David Ho1 other2025-10
Joseph Doherty1 other2025-10
Philip Liang1 other2020-07
Stephen From1 other2025-10
Victoria Carr-Brendel1 other2025-10
Fuad Ahmad2025-10
Randy Clark2025-10
Sammy Khalifa2018-01
Registry & provenance

Vicarious Surgical Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1666810
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Htg Molecular Diagnostics, IncMedical DevicesSeries B$65.3M$110.4Msame sector · same stage
Onkos Surgical, Inc.Medical DevicesSeries B$72.3M$595.7Msame sector · same stage
Eyegate Pharmaceuticals IncPharmaceuticalsSeries A$72.9M$92.6Mnetwork2 shared operators
Zenflow, Inc.Medical DevicesSeries B$75.3M$116.7Msame sector · same stage
Eximis Surgical Inc.Medical DevicesSeries B$40.6M$160.4Msame sector · same stage
Celsee Diagnostics, Inc.Medical DevicesSeries B$40.5M$135.3Msame sector · same stage
Carrot Inc.Other Health CareSeries B$51.0M$20.8Mnetwork1 shared operator · same stage
MedCrypt Inc.Medical DevicesSeries B$39.7M$45.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Prescient Surgical, Inc.Medical DevicesSeries A$3.5M83%
Think Surgical, Inc.Medical DevicesSeries D+$88.5M83%
Pristine Surgical LLCMedical DevicesSeries A$201.7M83%
Nascent Surgical, LLCMedical DevicesSeed$7.6M82%
SafeGuard Surgical, Inc.Medical DevicesSeed$5.9M82%
Minerva Surgical IncMedical DevicesSeries B$397.4M82%
Surgical Information Sciences, Inc.Medical DevicesSeed$27.4M81%
Derry Surgical Center, LLCMedical DevicesPre-Seed$765K81%
Frequently asked
How much funding has Vicarious Surgical Inc. raised?
Vicarious Surgical Inc. has raised approximately $55.9M in disclosed capital across 7 recorded financing rounds, aggregated from public filings.
What is Vicarious Surgical Inc.'s estimated valuation?
Provath's modeled valuation for Vicarious Surgical Inc. is approximately $51.2M (modeled range $26.4M–$71.8M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Vicarious Surgical Inc. at?
Vicarious Surgical Inc.'s latest modeled financing stage is Series B. Its most recent recorded round closed around Thu Oct 09.
What does Vicarious Surgical Inc. do and where is it based?
Vicarious Surgical Inc. operates in the Medical Devices sector, based in CHARLESTOWN.
Explore related

See where Vicarious Surgical Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Vicarious Surgical Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.